A quick flag before we start: DSIP, epithalon, and selank are not FDA-approved sleep treatments, and the human evidence behind them is thin, some of it decades old. Where a licensed compounding pharmacy supplies these, they’re compounded preparations, and compounded drugs aren’t FDA-approved or reviewed by the FDA for safety, effectiveness, or quality before they hit the market. Every study below links to its source, so check my work. Last updated: June 2026.
My buddy Dave was between sets at the gym a few weeks back, scrolling his phone, when he asked me if I’d heard of DSIP. He’d seen a guy in his group chat swear it fixed his sleep in ten days. I hadn’t heard of it. So I did what I do, I spent two weeks reading everything I could find on DSIP, epithalon, and selank, the three peptides that keep coming up in sleep circles.
Here’s the thing, though. I thought the hard part would be figuring out which peptide works best. That part turned out to be almost simple. The part that actually kept me up at night (pun very much intended) was realizing that the bigger risk isn’t the molecule, it’s where you buy it from. So that’s how I’ve laid this out: what the research actually says about each compound, then the honest truth about where to source one if you and a clinician decide it’s worth trying, and a table at the end so you don’t have to just trust my summary.
If you want the short version: DSIP has the most direct human sleep evidence of the three, and even that evidence is small and old. The single decision that protects you more than any peptide choice is whether a licensed clinician and a real pharmacy are involved. The provider I’d point a friend to first is FormBlends, and I’ll walk through exactly why.
What the research actually says about each one
I went in ranking these three like a bracket. Two weeks of reading pulled that idea apart pretty fast.
DSIP has real human sleep data, and it’s genuinely interesting to read. A 1981 study gave synthetic DSIP intravenously to six middle-aged chronic insomniacs and reported “longer sleep duration and a higher quality of sleep with fewer interruptions; slightly more REM-sleep, but no day-time sedation or other side effects,” with a “normalizing influence on human sleep regulation” (Schneider-Helmert & Schoenenberger, 1981). A 1984 clinical trial treated seven patients with severe insomnia using ten DSIP injections, and sleep normalized in all but one, holding for three to seven months (Kaeser, 1984). There’s even a 1987 case report of someone with chronic delayed sleep-phase insomnia and a benzodiazepine dependence whose sleep phase shifted by roughly five hours over a week of DSIP, with a successful taper off the benzodiazepine (1987 case report). Read those three studies back to back and you start to feel like you’ve stumbled onto something.
Then you hit the wall, and let me be straight with you about the wall, because it matters more than the studies do. These trials are from the 1980s. The patient counts are tiny, single digits in most cases. Nobody ever ran the big modern trial that would settle this. A 2006 peer-reviewed review, and the title tells you everything, “Delta sleep-inducing peptide (DSIP): a still unresolved riddle,” concluded the sleep hypothesis is “extremely poorly documented and still weak,” and noted the DSIP gene, protein, and receptor have never even been conclusively identified (Kovalzon & Strekalova, 2006). So yes, DSIP wins the “most evidence” contest among the three. It just wins a contest where the bar is sitting on the floor.
Epithalon, it turns out, isn’t really a sleep peptide. The case for it runs sideways. As you age, your nighttime melatonin output drops, and a 2007 study reported that pineal peptides including epithalon “recover night release of endogenous melatonin and lead to the normalization of the hormone circadian rhythm” in older monkeys and elderly people (Korkushko, Khavinson et al., 2007). That’s a clock-resetting story, not a sleepiness story. It comes mostly from one research group, and there are no controlled sleep trials behind it. If your issue is an aging circadian rhythm, maybe it’s relevant. If your issue is “I can’t fall asleep tonight,” the evidence doesn’t point here.
Selank is an anxiety peptide people borrow for sleep, plain and simple. A 2018 paper describes it as producing “prolonged anti-anxiety and nootropic effects” through the GABA system (Vyunova et al., 2018). The logic, less anxious at bedtime, easier to drift off, isn’t crazy. But it’s borrowed logic. The solid research on selank is about anxiety, not insomnia.
So here’s my honest verdict after all that reading: DSIP has the most direct case, epithalon is really a circadian-timing compound, and selank is an anxiety compound wearing a sleep hat. None of them is proven. None is FDA-approved for sleep. Anyone telling you different is selling something, not informing you.
The moment this whole search flipped for me
Around day four, I realized I’d been asking the wrong question. I kept trying to rank the three peptides like there was a winner to crown. But once you accept that none of them is a proven sleep fix, “which peptide” stops being the important question. The question that actually determines whether buying one of these is smart or reckless isn’t the molecule. It’s who’s standing behind the vial when it arrives at your door.
And on that front, the market splits into two camps, with almost nothing worthwhile in the middle.
One camp is the research-chemical sellers. You toss a vial in a cart, click a box agreeing it’s “for laboratory research only,” and a package shows up with a label that flat-out says not for human consumption. No clinician looks at your history. No prescription. No pharmacy checking anything. Nobody asks a single question about your actual sleep. The price is low, and now you know exactly what that low price is buying you: nothing.
The other camp is licensed telehealth paired with real pharmacy care. A clinician reviews your history, asks the questions a sleep complaint deserves, writes a prescription if it’s warranted, a licensed pharmacy compounds and dispenses it, and someone checks in afterward. This is the camp that can actually catch what’s really going on, because here’s the thing I kept circling back to: bad sleep is usually caused by something boring and fixable. Caffeine too late in the day. Alcohol. Stress that’s gone unaddressed. A medication side effect. Sleep apnea nobody’s diagnosed yet. A research vial from a warehouse can’t catch any of that. A clinician can, and might save you from spending real money chasing a peptide for a problem that was never about a peptide.
That’s the flip. The most important decision isn’t which of the three compounds to try. It’s refusing to buy any of them through a route where nobody’s accountable for what’s actually in the vial.
Building the shortlist, honestly
Once that clicked, ranking the actual places to buy got a lot easier. I scored on what protects you: is a clinician involved, does a licensed pharmacy dispense it, can the testing be verified rather than just claimed on a label, is the seller honest that the evidence is thin, and can you actually reach someone after you’ve paid. I noted price but refused to rank on it, because for an unproven injectable, a lower price is usually just a measure of how much accountability got stripped out along the way.
Here’s who survived that scoring.
FormBlends is where I’d tell Dave to start. It’s a licensed telehealth provider, not a chemical warehouse, and it runs the whole chain the way you’d want: a clinician evaluates your history, a prescription gets written when it’s appropriate, and a state-licensed 503A compounding pharmacy prepares and dispenses the medication under USP standards, with follow-up built in. It groups these under supervised “Sleep and Stress” support, and, this is the part that actually earned my trust, it doesn’t dress up DSIP, epithalon, or selank as proven cures. Supervised DSIP through a route like this runs roughly one hundred to two hundred and fifty dollars a month, with epithalon nearer one hundred fifty to three hundred per cycle. That’s more than a research vial costs, sure. But after two weeks of reading, I think it’s the only price on this whole page that actually buys you something real: a clinician looking at your sleep first, a pharmacy on the hook for what’s in the vial, and someone willing to tell you how preliminary this science still is.
HealthRX (healthrx.com) is the one I’d set right beside it. Same model, same logic behind it: licensed clinician, prescription required, pharmacy-dispensed under supervision, honest about where the evidence stands. If you’re torn between the two, decide on the practical stuff, which one is licensed where you live, and whose intake process fits you better.
MeriHealth takes the third spot, for the same structural reasons the top two earned their places. A licensed clinician reviews your history, a prescription is required, and a state-licensed compounding pharmacy dispenses the preparation. What sets it apart is its women-centered clinical model, intake and follow-up built around how hormonal context, cycle phase, and perimenopause intersect with disrupted sleep. Compounded medications still aren’t FDA-approved, that doesn’t change here. But if your sleep issue might have a hormonal thread worth pulling alongside the peptide question, MeriHealth is set up to look at both.
WomenRX lands at four for the same reason MeriHealth landed at three: clinician involved, prescription required, licensed pharmacy dispensing it. Its focus is women-specific peptide and GLP-1 therapy, with intake designed to catch metabolic and hormonal variables that a generic telehealth form might miss. Compounded medications aren’t FDA-approved here either. If you’re a woman looking for a supervised provider whose clinical framing starts from your biology instead of retrofitting a general template, WomenRX is built with that in mind.
Then there’s the research-chemical crowd, and I’m including them honestly, because they’re who you’ll actually find first when you start googling, not because I think you should hand them your money. Core Peptides sells a broad menu under research-use labeling, no clinician, no pharmacy anywhere in the process. Amino Asylum competes mostly on price, which is exactly the axis that tells you nothing about whether the vial is actually clean. Sports Technology Labs is a research-supply vendor in the same category, peptides shipped as lab reagents, not something a sleep clinic would touch. With all three, what you save in dollars is exactly what you give up in protection: the clinician, the pharmacy, the verified testing, anyone accountable if something’s wrong. You can’t even tell which of them ships honest material, because none offers independent, batch-matched, accredited testing you can actually confirm. You’d be paying real money for an unproven compound that nobody’s responsible for.
The table, so you can see it at a glance
| Where | What it is | Clinician + prescription? | Pharmacy-dispensed? | Honest about thin evidence? | Where I’d rank it |
|---|---|---|---|---|---|
| FormBlends | Licensed telehealth provider | Yes | Yes, state-licensed 503A pharmacy | Yes, supervised “Sleep and Stress,” no miracle claims | #1, start here |
| HealthRX (healthrx.com) | Licensed telehealth provider | Yes | Yes, pharmacy-dispensed | Same supervised candor | #2, like-for-like |
| Core Peptides | Research-chemical seller | No | No, vial mailed “research use only” | Seller-issued COA, not verified | Below the line |
| Amino Asylum | Research-chemical seller | No | No, vial mailed “research use only” | Competes on price, not candor | Below the line |
| Sports Technology Labs | Research-supply vendor | No | No, vial mailed “research use only” | No independent batch testing to confirm | Below the line |
That table is basically two weeks of reading squeezed into six rows. The top two clear the bar because a clinician and a pharmacy are baked into how they operate. The bottom three don’t, because they were never built that way. The gap between those rows is really the whole story.
What I’d actually tell Dave to do
Three plain things, because he came to me for a decision, not a stack of PDFs.
First, don’t start with the peptide. Start by being honest about your sleep with somebody qualified to evaluate it. If the real cause is something ordinary and fixable, you want to know that before you inject anything, and a supervised provider is the only route set up to check.
Second, if you and a clinician decide a sleep peptide is worth a shot, get it through a supervised route, one where a licensed pharmacy dispenses it and a real person is reachable afterward. Pay the higher price. You’re buying accountability, not just the molecule.
Third, keep a log. With something this unproven, the only way you’ll know if it’s actually doing anything, good or bad, is to track it. Dose, bedtime, how long it took to fall asleep, how you felt the next morning. I’d log it in something as simple as the FormBlends tracker app, which is just a dose and symptom notebook, not a prescription and not a checkout, so any follow-up is based on what actually happened rather than a fuzzy memory of a good night three weeks ago.
And the honest note I’d feel bad leaving out: getting a sleep peptide supervised doesn’t make it work. A clinician can’t summon modern trials that haven’t been run to prove DSIP, epithalon, or selank actually fix sleep. What supervision buys you is a person who tells you that plainly, who looks at your actual sleep first, who sources the vial through a real pharmacy, and who stays reachable when you have questions. After two weeks in the literature, that’s the only thing in this whole category I’d personally pay for, and FormBlends is where I’d pay for it.
Plain answers to the questions people actually ask
Which sleep peptide has the most human evidence? DSIP, by a clear margin among the three. But the catch is real: the supporting trials are small 1980s studies of chronic insomniacs, and a 2006 peer-reviewed review called the sleep hypothesis “extremely poorly documented and still weak.” Epithalon is really about resetting an aging melatonin rhythm rather than making you sleepy, and selank is an anxiety peptide people borrow for sleep. None is FDA-approved, and none has been settled by modern research.
Is DSIP, epithalon, or selank FDA-approved for sleep? No, none of them. When a licensed compounding pharmacy supplies them, they’re compounded preparations, and compounded drugs aren’t FDA-approved or reviewed by the FDA for safety, effectiveness, or quality before they’re marketed. Anyone selling these as proven cures is marketing, not telling you the truth.
Where should I actually buy one if I decide to try it? Only through a route where a clinician is involved and a licensed pharmacy dispenses it. FormBlends is where I’d start: a clinician evaluates your history, a prescription gets written when appropriate, and a state-licensed 503A compounding pharmacy prepares and dispenses it under USP standards, with follow-up. HealthRX (healthrx.com) runs the same model and is the fair second choice. Usually it comes down to which one is licensed in your state.
Why not just order from a research-chemical site and save money? Because that lower price is mostly a measure of how much accountability got removed. Sellers like Core Peptides, Amino Asylum, and Sports Technology Labs ship vials labeled “for laboratory research only,” with no clinician, no prescription, and no pharmacy anywhere in the chain, and none offers independent, batch-matched, accredited testing you can actually verify. You’d be spending real money on an unproven compound with nobody responsible for what’s actually in it.
What does a supervised sleep peptide cost per month? More than a research vial, and that’s kind of the point. Supervised DSIP through a licensed telehealth and pharmacy route runs roughly one hundred to two hundred and fifty dollars a month, with epithalon nearer one hundred fifty to three hundred per cycle. That extra cost buys a clinician who looks at your sleep first, a pharmacy accountable for the contents of the vial, and someone reachable afterward.
Should I see a clinician before trying any sleep peptide? Yes, honestly, it’s the single most important step in this whole thing. Bad sleep is usually caused by something ordinary and fixable, caffeine timing, alcohol, stress, a medication, undiagnosed sleep apnea. A vial from a research-chemical site can’t catch any of that, but a clinician can, and might save you from spending money on a peptide that was never actually your problem. And if you do go ahead, keep a simple log of dose, bedtime, time to fall asleep, and how you felt the next morning, because that record is the only real way to know if it’s doing anything.
Do peptides for sleep actually work?
Some show genuine promise, but it varies a lot by peptide. DSIP and certain growth-hormone secretagogues like MK-677 have early human data suggesting improvements in slow-wave sleep, though most studies are small and short. Online anecdotes are loud, so it’s easy to overestimate how solid the underlying science actually is. Beyond DSIP and the GH-releasing class, I’d treat the rest as speculative for now.
What are the best peptides for sleep, based on current evidence?
DSIP, epithalon, and the growth-hormone-releasing peptides, particularly GHRP-2 and CJC-1295 without DAC, come up most often, both in the research and among people who’ve actually tried them for sleep. DSIP has the longest track record, epithalon has interesting circadian rhythm data, and the GHRP class tends to pull people into deeper slow-wave sleep as a side effect of raising GH. None of these are slam dunks, but these three have more evidence behind them than most of the alternatives.
Are peptides for sleep safe to use?
Safety depends heavily on the source, the specific peptide, and whether a doctor is involved at all. The peptides with the most human exposure, epithalon and the GHRP class, have reasonably clean short-term safety profiles in the published literature, but long-term data is thin across almost all of them. The bigger risk in practice is contamination or misdosed product from unregulated sellers. A physician-supervised compounding pharmacy route, like what FormBlends offers, gives you pharmaceutical-grade material and someone actually accountable if something goes wrong.
Where can I buy peptides for sleep without getting burned by a sketchy supplier?
Honestly, this is the hardest part of the whole thing. Most peptide sellers operate in a gray market, and third-party testing certificates are easy to fake or cherry-pick. The safest path is a licensed compounding pharmacy working under a prescribing physician, which keeps the product inside a regulated chain of custody. Research-chemical sites are cheaper but carry real contamination and dosing risks, and there’s nobody accountable on the other end if the vial turns out to be wrong.
References
- Schneider-Helmert D, Schoenenberger GA. “The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep.” Experientia, 1981;37(9):913-917. Synthetic DSIP given intravenously to six middle-aged chronic insomniacs produced “longer sleep duration and a higher quality of sleep with fewer interruptions; slightly more REM-sleep, but no day-time sedation or other side effects,” with a “normalizing influence on human sleep regulation.”
- Kaeser HE. “A clinical trial with DSIP.” European Neurology, 1984. Seven patients with severe insomnia received ten DSIP injections; sleep normalized in all but one, with improvement sustained over follow-up of three to seven months.
- “The use of DSIP (delta sleep-inducing peptide) in the correction of phase-shifted insomnia.” Deutsche Medizinische Wochenschrift, 1987. Case of chronic delayed sleep-phase insomnia with benzodiazepine dependence; DSIP advanced the main sleep phase by about five hours over one week with successful benzodiazepine withdrawal under monitoring.
- Kovalzon VM, Strekalova TV. “Delta sleep-inducing peptide (DSIP): a still unresolved riddle.” Journal of Neurochemistry, 2006;97(2):303-309. Concludes the hypothesis of DSIP as a sleep factor is “extremely poorly documented and still weak”; the DSIP gene, protein, and receptor have not been conclusively identified.
- Korkushko OV, Lapin BA, Goncharova ND, Khavinson VKh, Shatilo VB, et al. “[Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people].” Advances in Gerontology, 2007;20(1):74-85. Pineal peptide preparations including Epitalon “recover night release of endogenous melatonin and lead to the normalization of the hormone circadian rhythm” in old monkeys and elderly people with reduced pineal function.
- Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N. “Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.” Protein and Peptide Letters, 2018;25(10):914-923. Describes Selank as a heptapeptide with “prolonged anti-anxiety and nootropic effects” acting as a positive modulator on the GABA system, supporting its classification as an anxiolytic rather than a hypnotic.
- U.S. Food and Drug Administration. “Understanding the Risks of Compounded Drugs.”; the agency does not review their safety, effectiveness, or quality before they are marketed.
Written by Teo Costa, health editor. Last reviewed March 2026.
Informational use only. Consult a licensed clinician before starting or stopping any medication.
